Submit Manuscript

Pakistan Journal of Biological Sciences

Year: 2013 | Volume: 16 | Issue: 3 | Page No.: 101-111
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

ABSTRACT

Modern medicine has helped to a great extent to eradicate and cure several diseases of mankind and animals. But the existence of incurable diseases like cancer, Acquired Immunodeficiency Syndrome (AIDS), diabetes or rheumatoid arthritis, side effects of allopathic medicine, increasing trend of antibiotic resistance and chemicals and biopesticides causing dietary risk have made the situation more critical than ever before. Thus, it has become a matter of concern for the scientists and researchers to develop novel therapies. Bacteriophage therapy to treat pathogenic bacterial infections, virophage therapy for conservation of global system and avian egg yolk antibody therapy for designing prophylactic strategies against Gastrointestinal (GI) diseases are interesting approaches. Others include the use of cytokines as adjunctive immunomodulators, gene therapy focusing on diseases caused by single gene defects, RNAi technology to suppress specific gene of interest and apoptins for cancer treatment. Stem cell therapy against several diseases and ailments has also been discussed. The use of nanoparticles for better drug delivery, even though costly, has been given equal importance. Nevertheless, immunomodulation, be it through physiological, chemical or microbial products, or through essential micronutrients, probiotics, herbs or cow therapy prove to be cost-effective, causing minimum adverse reactions when compared to allopathy. Development in the field of molecular biology has created an enormous impact on vaccine development. The present review deals with all these novel and emerging therapies essential to safeguard the health of humans and companion animals.
PDF Abstract XML References Citation
Received: November 23, 2012;   Accepted: February 12, 2013;   Published: March 16, 2013

How to cite this article

Kuldeep Dhama, Sandip Chakraborty, Mahima, Mohd. Yaqoob Wani, Amit Kumar Verma, Rajib Deb, Ruchi Tiwari and Sanjay Kapoor, 2013. Novel and Emerging Therapies Safeguarding Health of Humans and Their Companion Animals: A Review. Pakistan Journal of Biological Sciences, 16: 101-111.

DOI: 10.3923/pjbs.2013.101.111

URL: https://scialert.net/abstract/?doi=pjbs.2013.101.111

Search

INTRODUCTION

The state of underdevelopment can be studied in the limelight of its relation with infectious diseases that has a negative impact on the production of industrial goods and animal proteins, especially in underdeveloped countries (Astudillo and Rosenberg, 1983). In this context, infectious diseases act as factors contributing to the state of underdevelopment especially in country like India. The impact of animal and poultry diseases like foot and mouth disease (Verma et al., 2008a, 2012), brucellosis (Kumar et al., 2009), mycoplasmosis (Kumar et al., 2011, 2012a), chicken infectious anaemia (Dhama et al., 2002; Bhatt et al., 2011) is also very important, mostly because of animal health restrictions based on these endemic diseases. Loss of health in pet animals due to diseases like canine parvovirus (Singh et al., 2013), campylobacteriosis (Kumar et al., 2012b, c), salmonellosis (Verma et al., 2007), canine distemper or Feline Infectious Peritonitis (FIP) hearts the sentiment of owners. Moreover, the lethal diarrhoea caused by colibacillosis (Malik et al., 2012), rota viruses, corona virus, the H5N1 avian influenza and the zoonotic disease like campylobacteriosis, salmonellosis (Verma et al., 2008b) rabies are quiet noteworthy in the context of safeguarding public health (Dhama et al., 2005a; Brownlie et al., 2006; Lambey et al., 2009; Dhama et al., 2009; Pawaiya et al., 2009; Singh et al., 2009; Verma et al., 2011a, b; Patyal et al., 2011; Hansa et al., 2012; Deb et al., 2012).

Modern medicine has done much to eradicate and cure disease, but it has failed in some areas due to the existence of incurable diseases like cancer, AIDS, diabetes and rheumatoid arthritis. Cancer affects one in every three persons born in developed countries and is a major cause of sickness and death throughout the world and therapeutic approach is critical due to critical immune response (Cavallo et al., 2011; Mahima et al., 2012a). HIV infection and AIDS are disproportionately afflicting Third World countries, where substantial adult communities and villages are literally being annihilated as because there is no known cure for HIV/AIDS and due to involvement of high costs of current antiviral therapy (Livingston, 1993). Similarly, therapeutic approaches against diabetes and rheumatoid arthritis are critical (www.cimzia.com).

Long term life regimen of allopathic medicine has potential side effects. Uncontrolled and inappropriate use of antibiotics that have promised much in elimination of major diseases of humans and animals, result in resistance, critical for the future of antimicrobials (Raghunath, 2008; Kumar et al., 2012b; Taddele et al., 2012). Systemic pesticides used in genetically modified crops like Bt corn, account for 60% (approx.) of dietary risk in domestic crops, ultimately proving troublesome to human health (Monosson, 2005).

Due to advancement in the field of science, field of molecular biology and biotechnology along with nanotechnology are enriched which have led to the generation of many novel therapies (Bartol et al., 1999; Chakravarthi and Balaji, 2010; Shirley et al., 2011). Therefore, the present review discusses these novel technologies involving bacteriophage, virophage, avian egg antibody, cytokine, gene, siRNA, apoptins, stem cells, nanomedicine, immune system, vaccines, probiotics and herbs safeguarding human and animal health.

Bacteriophage therapy: Bacteriophages can be used for checking bacterial contamination food materials, controlling water-borne infections and food-borne pathogens and remarkably for a variety of severe infections. These are magical viruses that kill bacteria by lysing them and are particularly very useful for treating antibiotic-resistant infections in animals and humans (Tiwari et al., 2012). Oral administration or topical application of phages have been attempted for a wide range of bacterial infections, caused by wounds or surgical intervention (Mathur et al., 2003; Tiwari et al., 2011, 2012) including inflammation of larynx, gums, teeth, sinuses, conjunctiva, infections of skin, gastrointestinal tract, urinary tract, skin infections, burns, boils; and interestingly, cocktailed against some bacteria viz., P. aeruginosa, Staph. aureus and E. coli (Sulakvelidze et al., 2001; Hanlon, 2007; Rhoads et al., 2009; Lu and Koeris, 2011; Sulakvelidz, 2011). Bacteriophages can be particularly very effective in treating drug-resistant bacterial infections in humans and animals including poultry. Therapeutic applications include treating various bacterial infections, viz., E. coli, P. aeruginosa, K. pneumoniae, S. aureus, S. pyogenes, Bacillus anthracis, Salmonella spp., Campylobaeter jejuni, C. coli, Listeria monocytogenes and others (Tiwari et al., 2012).

Virophages: Virophages/satellite viruses depend on the coinfection of their host by another virus inhibiting or damaging the reproduction of the auxiliary virus, examples include Sputnik, Mavirus and Organic Lake phages (Krupovic and Cvirkaite-Krupovic, 2011; Fischer, 2011; Fischer, 2012; Desnues et al., 2012). Sputnik can have major effects on ocean nutrient cycles and climate and may play a crucial role in conservation of global systems by regulating the host virus interaction, carbon influx in organic lake, growth and death of planktons (La Scola et al., 2008; Monier et al., 2008).

Yolk antibody therapy/avian egg antibody therapy: Now-a-days, there is progress to use chicken egg as source of antibodies for the prevention and treatment of gut associated infections (Michael et al., 2010), wherein, after immunization, the specific antibodies, otherwise known as IgY are transported to the egg yolk and they can then be separated without sacrificing the bird. Oral administration of IgY has been tried and found useful in treatment of man and animals against microbes including viruses like rotaviruses, bovine coronavirus; bacteria like enterotoxigenic Escherichia coli, Campylobacter jejuni, Yersinia ruckeri, Salmonella spp., Pseudomonas, Edwardsiella tarda and Staphylococcus aureus (Mine and Kovacs-Nolan, 2002; Kovacs-Nolan and Mine, 2004). The Egg Yolk Antibody (EYA) therapy has also shown promising therapeutic results in cases of infectious pathogens/diseases of poultry viz., infectious bursal disease (IBD), New Castle disease (ND), avian influenza subtype H9N2, salmonellosis, campylobacteriosis, and Pseudomonas aeruginosa, Salmonella enteritidis, Staphylococcus aureus and Eimeria tenella or E. maxima (Yegani and Korver, 2007; Rahimi et al., 2007; Da Silva and Tambourgi, 2010; Dhama et al., 2011a).

Cytokine therapy: The cytokines are used as adjunctive immunomodulators in a variety of infectious diseases (Hafler, 2007; Dhama et al., 2008a). The classical examples include the use of recombinant α-interferons and nucleoside analogs for hepatitis B virus (HBV), pegylated interferons and ribavirin for hepatitis C virus (HCV) (Forton and Karayiannis, 2006; Trapero-Marugan et al., 2006), HIV-associated cryptococcal meningitis (Antachopoulos and Roilides, 2005) and Crohn’s disease (Pizarro and Cominelli, 2007). The immunoglobulin Fc fragment based cytokines provides superior therapeutic approach (Jazayeri and Carroll, 2008). Nevertheless, the development of new vaccines necessitates the development of new types of adjuvants to ensure an appropriate immune response (Nicholls et al., 2010), examples include the use of cytokines like IL-7, 12 and 15 as mucosal vaccine adjuvants, Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) along with Monocyte Chemotactic Proteins (MCPs) and Macrophage Inflammatory Proteins (MIPs) to increase recruitment of blood-borne dendritic cells and monocytes to interstitial sites of vaccine delivery etc.

Gene therapy: Gene therapy finds its application in various diseases caused by single gene defect (Thalassemia, sickle cell anemia, cystic fibrosis, haemophilia and muscular dystrophy). The various therapeutic approaches in this context include somatic gene therapy, germ line therapy and use of both viral and non-viral vectors. Transfection of the cell is achieved by electroporation, gene gun, sonoporation, magnetofection, use of oligonucleotides, naked DNA injection, lipoplexes, dendrimers and inorganic nanoparticles (Agha-Mohammadi and Lotze, 2000; Goverdhana et al., 2005). Gene therapy is used in case of lymphoma, retinitis pigmentosa, diabetes etc., (Woods et al., 2006; Cepko, 2012; Callejas et al., 2013).

siRNA therapy: Suppression of specific genes of interest by synthetic dsRNA has made RNAi a valuable research tool. Short interfering RNA was easier to introduce in comparison to long dsRNA strands into mammalian cells (Paddison et al., 2002). This RNAi has been successfully used in treatment of various viral infection like respiratory syncytial virus, herpes simplex virus type 2 and measles infection. Apart from infectious diseases they are also helpful in inhibiting virus induced cancerous growth, have receptor-knockdown activity and plays role in gene silencing (Sah, 2006; Jiang and Milner, 2002; Crowe, 2003; Kusov et al., 2006; Jia et al., 2006; Li et al., 2006; Hu et al., 2005; Raoul et al., 2006).

Apoptins: Drugs directed against defective apoptotic pathways (apoptins) may act as a double-edged sword and forms an interesting target of cancer treatment (Wong, 2011). Approaches for apoptin based therapy to treat cancer include use of agents like oblimersen sodium Bcl-2 antisense oblimer, oblimersen in myeloid leukaemia, use of mutant p53 in pancreatic cancer, silencing of Bmi-1 in MCF breast cancer cells, use of XIAP antisense oligonucleotides in lung cancer and transfection of anti-sense survivin in squamous cell carcinoma (Rai et al., 2008; Morton et al., 2010; Suzuki and Matsubara, 2011; Ohnishi et al., 2006; Sharma et al., 2005). Apart from that, chicken anaemia virus VP3 protein is also used in treatment of cancer (Natesan et al., 2006).

Stem cell therapy: Introduction of new adult stem cells into damaged or injured tissue forms the basis of stem cell therapy (Lindvall and Kokaia, 2006). Haematopoietic stem cell therapy is used for treating cancer; other uses in human and veterinary medicine include treatment of neurological damages viz. Parkinson’s and Alzheimer’s disease, spinal cord injury, treatment of equine tendinopathies, Crohn’s disease, heart damage, diabetes, inhibiting acute pancreatitis, lung therapy, Acute Respiratory Distress Syndrome (ARDS), corneal epithelial reconstruction etc (Androutsellis-Theotokis et al., 2008; Cummings et al., 2005; Centeno et al., 2008; Ribitsch et al., 2010; Jiang et al., 2012; Fryer et al., 2013; Wen et al., 2013; Ardhanareeswaran and Mirotsou, 2013; Cardenes et al., 2013; Menzel-Severing et al., 2013). However, there are many barriers like biological, technical and clinical that have to be crossed before using this therapy in clinics (Ouyang and Yang, 2013).

Nanomedicines: Since 2000, there is boom of nanotechnology in science, engineering, technology and even in society. This technology can be used in medical and veterinary field for diagnosis, treatment, and prevention of various diseases (Kato, 2013) especially through drug delivery, imaging and vaccine adjuvant (Irache et al., 2011; Underwood and van Eps, 2012). Nanomedicine forms the application part of nanotechnology. The common nanomedicine vehicles are solid drug nanoparticles, polymer-based carriers and nanoemulsions that can be used for treatment of various infectious diseases including retroviruses (Siccardi et al., 2013). Gold-conjugated nanoparticles improve the therapeutic properties of drugs by selectively targeting certain organs based on their size and charge (Minchin, 2008; Allen and Cullis, 2004), especially anticancer agents. For example, use of carbon nanoparticles (Hollmer, 2012) for paclitaxel or liposome for doxorubicin (Garde, 2012); polymers and liposomes for delivery of camptothecins and platinum (II) drugs (Kieler-Ferguson et al., 2013) and so also use of polyethylene glycol for better delivery of several antibiotics (Trafton, 2012).

Immunotherapy: The main objective of immunotherapy is to control an immune response (Fraile et al., 2012). Use of monoclonal antibodies is an interesting approach (Deb et al., 2013), wherein, they are coupled with drugs (magic bullets) (Nielsen et al., 1986). Other immunomodulators include a diverse groups of physiological (neuroendocrine hormones and glucocorticoids, neurotransmitters and neuropeptides, thymic products (Dan and Lall, 1998; Singh et al., 1998; Wilckens and De Rijk, 1997), microbial (heat killed or formaldehyde treated anaerobic suspension of Propionibacterium acnes) (Becker et al., 1989) and plant/herbal products (Mahima et al., 2012a). Synthetic chemical compounds like levamisole, imuthiol, avridine, biostim etc. are good immunomodulators (Coppel and Kulkarni, 2012).

Therapeutic vaccines: Prevention of diseases by vaccination has been an integral part of health management programs as this has successfully prevented many important diseases in a cost-effective manner (e.g., inactivated vaccine against warts in cattle) (Ferro and Mordini, 2004; Singh et al., 2008; Pathania et al., 2011). Molecular biology has created an enormous impact on vaccine development, leading to development of DNA vaccines (targeted animal diseases include FMD, tuberculosis, Brucellosis, Rabies, Canine distemper, Johne’s disease), subunit vaccine (against Infectious bovine rhinotracheitis and rabies), anti-idiotypic and virosome vaccine, virus-based nanoparticles and virus like particles, biotechnologically engineered vaccine against pseudorabies etc., (Dhama et al., 2008b; Mengeling et al., 1997). Importantly, plant based oral vaccine have gained popularity in human medicine and has been found to be protective against diseases like Hepatitis B, Human Immunodeficiency Virus (HIV), Cholera, Tetanus, Malaria, Measles, Japanese encephalitis (JE) and Influenza (Mercenier et al., 2001; Daniell et al., 2009).

Design and development of therapeutic cancer vaccines has proven to be an enormous challenge (Pejawar-Gaddy and Finn, 2008). But with the development of whole tumour cell vaccines, as is tumor-derived Chaperone-rich Cell Lysate (CRCL) vaccine, genetically modified tumor cell vaccines viz. immunizations with canine tumor cell lines transfected with human GM-CSF, peptide vaccines by using Wilms’ tumor gene, heat shock protein vaccine, dendritic cell vaccine etc. (De Gruijl et al., 2008; Li et al., 2008; Hogge et al., 1999; Oka and Sugiyama, 2010; Blachere and Srivastava, 1995; Adamson et al., 2009) have made the management of wide variety of tumors easier than earlier.

Nutritional immunomodulation/therapy: Nutrition plays a pivotal role in modulation of immunity and there must be adequate supply of nutrients for the proper functioning of immune system. Nutritional deficiency affect immune cells and inhibits vital functions,like the cytokine responses (Katona and Katona-Apte, 2008) for which there is need to supply essential micronutrients viz. Vitamins A, D, E, C, B6, folate, B12 (Ramakrishnan et al., 2004; Veldman et al., 2000; Meydani et al., 2005; Haertel et al., 2004; Leklem, 2001; Dhur et al., 1991; Tamura et al., 1999) and trace elements viz. selenium, zinc, copper and iron (Chaudhary et al. 2010, Mahima et al., 2012b and Mahima and Mudgal, 2012; Cuevas and Koyanagi, 2005; Bonham et al., 2002; Openheimer, 2000) in the diet. Leptin is considered as an emerging cytokine-like immune regulator found to be effective in nutritional problems (Cunningham-Rundles et al., 2005).

Probiotics: Probiotics (direct feed microbials) are naturally occurring and selected beneficial live microorganisms that create a positive impact on the physiological status of the host (Dhama and Singh, 2010). Probiotics include bacteria, fungi and yeast that create an unfavourable atmosphere for the pathogenic microbes in gastrointestinal tract (Bengmark, 1998). Generally, live apathogenic bacterial strains belonging to genus Lactobacillus, Streptococcus or Enterococcus, are used in livestock and poultry (Balevi et al., 2001; Dhama et al., 2008c, 2011b. Bacillus, Aspergillus, Saccharomyces and others are also being used.

Various studies have proved this for example increase in circulating antibody secreting cells by Lactobacillus in diarrhoea (Kaila et al., 1992) and enhancement of intestinal IgA production by Bifidobacterium bifidum (Park et al., 2002) etc. Probiotics have been found to enhance immunity and prevent various enteric infectious diseases caused by bacterial, fungal, protozoan and viral agents. These have been proven to be protective and combating various harmful pathogens viz. E. coli, S. aureus, Salmonella spp., Clostridium perfringens, Listeria monocytogenes, Campylobacter jejuni, Yersinia enterocolitica, Candida albicans, coccidian parasites (Eimeria spp.) etc. (Dhama et al., 2008c, 2011b). For best results, a multi strain probiotic should be used timely.

Herbal therapy: Globally many researches are going on role of plants and their extracts in enhancing the immunity of man and animals (Mahima et al., 2012a). Historically, various plants have been used in traditional system of India in the name of Rasayanas, which increases the resistance of the body against various pathogens (Tan and Vanitha, 2004). Various herbs viz., tulsi, ginger, chilli, turmeric, onion, garlic, spices, coriander etc are traditionally used for the treatment of different ailments based on Indian Traditional knowledge. Plants are source of phytochemicals that can have anti-microbial, antiviral or antifungal and immunomodulating activities. Some of the examples of medicinal plants are Tinospora cordifolia, Piper sarmentosum, Glycyrrhiza species, Gymnema species, Centella asiatica, Camellia sinensis, Crataegus species and Olea europaea, which can be used for treating the chronic diseases viz., diabetes, blood pressure, high cholesterol, rheumatoid arthritis etc (Mahima et al., 2012a). Plants are also used for the treatment of many parasitic diseases including malaria, toxoplasmosis, helminth infestations, chagas disease etc. Vinca alkaloids (vinblastine and vincristine) from the Madagascar periwinkle, (Catharanthus roseus G.); Paclitaxel from bark and other parts of Taxus brevifolia, Taxus Canadensis and Taxus baccata; Camptothecin, (from Camptotheca acuminate); Epipodophyllotoxin (from Podophyllum species) and Homoharringtonine (from the Chinese tree Cephalotaxus harringtonia var. Drupacea) have been used as anticancer drugs for treatment of ovarian cancer, breast cancer and lung cancer. Fresh Allium sativum, called ajoene, appears to protect CD8+ cells from attack by HIV, gives protection against human cytomegalovirus (HCMV) in a dose dependent manner (Guo et al., 1993) for example Piper longum has anti-tumour activity (Sunila and Kuttan, 2004). The roots of Astragalus, Isatis and Achyranthes significantly improve the immunity (Hashemi and Davoodi, 2012).

Cow therapy: The concept of cow therapy is based on the use of five constituents viz., milk, curd, ghee, urine and dung extract obtained from Indian Zebu cow, thus also known as Panchagavya (Verma, 2005). Panchagavya plays an important role in Ayurveda system of medicine and has got mention in ancient Indian literature as it enhances the body resistance and refractoriness to infections (Dhama et al., 2005b). Panchagavya/cowpathy has been reported to be useful for the treatment of several disorders and diseases like allergies, colds, cough, renal disorders, gastrointestinal track disorders, wound healing, skin infections, aging, intoxications, tuberculosis, chicken pox, hepatitis, leprosy etc. It is also being explored to treat deadly diseases like AIDS, diabetes, asthma, heart diseases, arthritis and others. Panchagavya and Ark have been found to be useful against flu viruses (Chauhan et al., 2001; Dhama et al., 2005b). Cow urine has been demonstrated to have potent anti-cancer activity and bioenhancer of drugs (Dhama et al., 2005c). Gauloka Peya (meaning 'drink from the land of cow') is having medicinal properties and is prepared by incorporating distilled and sterile cow urine mixed with water and herbs like brahmi and basil (Rahman, 2010).

CONCLUSION AND FUTURE PERSPECTIVES

The development in the field of molecular biology and nanobiotechnology has increased the versatility of therapeutic approaches to control various diseases and ailments. Thus, contributing to the improvement of health status of individual and accelerated growth of biological science at a rapid pace has the potential for significant advances in medical and veterinary public health. DNA technologies have revolutionalized modern science and find its application in the management of many incurable and chronic diseases of humans as well as animals. Stem cell therapy has the ability to change the face of human diseases as well as to alleviate sufferings. Nowadays, principles that govern the immune response are used in tailor-made vaccines against many noninfectious human diseases viz. cancers and autoimmune disorders. Nutritional immunomodulation helps in better economic outcome in the livestock sector. The concept of probiotic supplementation in feed is promising to maintain growth and production along with protecting health and boosting immunity without any side effects or public health hazard. Similarly, Ayurveda and Rashayanas are also preferred by a large portion of Indian population as they are cost effective and free from side effects. The IgY technology offers great future opportunities for designing prophylactic strategies against infectious GI diseases in humans and animals. Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices in near future. The application of all these therapies under various circumstances will ultimately safeguard health. Nevertheless, it should always be kept in mind that application of various novel therapies require judicious approaches to become fruitful in a better way.

REFERENCES

  1. Adamson, L., M. Palma, A. Choudhury, I. Eriksson and B. Nasman-Glaser et al., 2009. Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production. Scand. J. Immunol., 69: 529-536.
    CrossRefDirect Link
  2. Allen, T.M. and P.R. Cullis, 2004. Drug delivery systems: Entering the mainstream. Science, 303: 1818-1822.
    CrossRefDirect Link
  3. Androutsellis-Theotokis, A., M.A. Rueger, H. Mkhikian, E. Korb and R.D.G. McKay, 2008. Signaling pathways controlling neural stem cells slow progressive brain disease. Cold Spring Harb. Symp. Quant. Biol., 73: 403-410.
    CrossRefDirect Link
  4. Antachopoulos, C. and E. Roilides, 2005. Cytokines and fungal infections. Br. J. Haematol., 129: 583-596.
    CrossRefDirect Link
  5. Astudillo, V.M. and F.J. Rosenberg, 1983. Relationships between animal viral diseases and socio-economic development. Rev. Sci. Tech. Off. Int. Epiz., 2: 1013-1036.
    Direct Link
  6. Bartol, F.F., C.E. Zorn, D.R. Mulvaney and J. Wower, 1999. Animal Biotechnology and industry: Challenges and opportunities in the real world. Proceedings of the Auburn University Agricultural Conference. January 14-15, 1999, Deptartement of Animal and Dairy Sciences, pp: 16-24.
  7. Balevi, T., U.S. Ucan, B. Cokun, V. Kurtolu and I.S. Cetingul, 2001. Effect of dietary probiotic on performance and humoral immune response in layer hens. Br. Poult. Sci., 42: 456-461.
    CrossRefPubMedDirect Link
  8. Becker, A.M., A. Janik, E.K. Smith, C.A. Sousa and B.A. Peters, 1989. Propionibacterium acnes immunotherapy in chronic recurrent canine pyoderma: An adjunct to antibiotic therapy. J. Vet. Internal Med., 3: 26-30.
    CrossRefDirect Link
  9. Bengmark, S., 1998. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut, 42: 2-7.
    CrossRefDirect Link
  10. Tan, B.K.H. and J. Vanitha, 2004. Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: A review. Curr. Med. Chem., 11: 1423-1430.
    CrossRefPubMedDirect Link
  11. Bhatt, P., S.K. Shukla, M. Mahendran, K. Dhama, M.M. Chawak and J.M. Kataria, 2011. Prevalence of Chicken Infectious Anaemia Virus (CIAV) in commercial poultry flocks of Northern India: A serological survey. Transbound. Emerg. Dis., 58: 458-460.
    CrossRefPubMed
  12. Blachere, N.E. and P.K. Srivastava, 1995. Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors. Semin. Cancer Biol., 6: 349-355.
    CrossRefDirect Link
  13. Bonham, M., J.M. O'Connor, B.M. Hannigan and J.J. Strain, 2002. The immune system as a physiological indicator of marginal copper status? Br. J. Nutr., 87: 393-403.
    CrossRefDirect Link
  14. Brownlie, J., C. Peckham, J. Waage, M. Woolhouse and C. Lyall et al., 2006. Foresight. Infectious diseases: Preparing for the future future threats. Office of Science and Innovation. http://www.bis.gov.uk/assets/foresight/docs/infectious-diseases/t1.pdf.
  15. Callejas, D., C.J. Mann, E. Ayuso, R. Lage and I. Grifoll et al., 2013. Treatment of diabetes and long-term survival following insulin and glucokinase gene therapy. Diabetes.
    CrossRef
  16. Cavallo, F., C. De Giovanni, P. Nanni, G. Forni and P.L. Lollini, 2011. The immune hallmarks of cancer. Cancer Immunol. Immunother, 60: 319-326.
    CrossRefDirect Link
  17. Centeno, C.J., D. Busse, J. Kisiday, C. Keohan, M. Freeman and D. Karli, 2008. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician, 11: 343-353.
    PubMedDirect Link
  18. Cepko, C.L., 2012. Emerging gene therapies for retinal degenerations. J. Neurosci., 32: 6415-6420.
    CrossRefDirect Link
  19. Chakravarthi, V.P. and N. Balaji, 2010. Applications of nanotechnology in veterinary medicine. Vet. World, 3: 477-480.
    CrossRefDirect Link
  20. Chauhan, R.S., B.P. Singh and L.K. Singhal, 2001. Immunomodulation with kamdhenu ark in mice. J. Immunol. Immunopathol., 3: 74-77.
    Direct Link
  21. Crowe, S., 2003. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS, 17: S103-S105.
    PubMedDirect Link
  22. Cuevas, L.E. and A. Koyanagi, 2005. Zinc and infection: A review. Ann. Trop. Paediatr., 25: 149-160.
    CrossRefDirect Link
  23. Cummings, B.J., N. Uchida, S.J. Tamaki, D.L. Salazar and M. Hooshmand et al., 2005. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci., 102: 14069-14074.
    Direct Link
  24. Cunningham-Rundles, S., D.F. McNeeley and A. Moon, 2005. Mechanisms of nutrient modulation of the immune response. J. Allergy Clin. Immunol., 115: 1119-1128.
    CrossRefDirect Link
  25. Dan, G. and S.B. Lall, 1998. Neuroendocrine modulation of immune system. Indian J. Phamacol., 30: 129-140.
    Direct Link
  26. Daniell, H., N.D. Singh, H. Mason and S.J. Streatfield, 2009. Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci., 14: 669-679.
    CrossRefDirect Link
  27. De Gruijl, T.D., A.J. Van den Eertwegh, H.M. Pinedo and R.J. Scheper, 2008. Whole-cell cancer vaccination: From autologous to allogeneic tumor- and dendritic cell-based vaccines. Cancer Immunol. Immunother., 57: 1569-1577.
    CrossRef
  28. Deb, R., S. Chakraborty, U. Singh, S. Kumar and A. Sharma, 2012. Major Viral Diseases of Cattle. In: Infectious Diseases of Cattle, Deb, R. (Ed.). Satish Serial Publishing House, India, pp: 95-96.
  29. Deb, R., S. Chakraborty, B.M. Veeregowda, A.K. Verma, R. Tiwari and K. Dhama, 2013. Monoclonal antibody and its use in the diagnosis of livestock diseases. Adv. Biosci. Biotechnol.
  30. Dhama, K. and S.D. Singh, 2010. Probiotics improving poultry health and production: An overview. Poult. Punch., Vol. 26.
  31. Dhama, K., R.S. Chauhan and L. Singhal, 2005. Anti-cancer activity of cow urine: Current status and future directions. Int. J. Cow Sci., 1: 1-25.
  32. Dhama, K., R.S. Chauhan, J.M. Kataria, M. Mahesh and T. Simmi, 2005. Avian Influenza: The current perspectives. J. Immunol. Immunopathol., 7: 1-33.
    Direct Link
  33. Dhama, K., R.S. Chauhan, M. Mahendran and S.V.S. Malik, 2009. Rotavirus diarrhea in bovines and other domestic animals. Vet. Res. Commun., 33: 1-23.
    CrossRefDirect Link
  34. Dhama, K., J.M. Kataria, B.B. Dash, N.S. Kumar and S. Tomar, 2002. Chicken infectious anaemia-A Review. Indian J. Comp. Microbiol. Immunol. Infect. Dis., 23: 1-15.
  35. Dhama, K., M. Mahendran, R.S. Chauhan and S. Tomar, 2008. Cytokines-their functional roles and prospective in veterinary practice: A review. J. Immunol. Immunopathol., 10: 79-89.
    Direct Link
  36. Dhama, K., M. Mahendran, P.K. Gupta and A. Rai, 2008. DNA vaccines and their applications in veterinary practice: Current perspectives. Vet. Res. Commun., 32: 341-356.
    CrossRefDirect Link
  37. Dhama, K., M. Mahendran, S. Tomar and R.S. Chauhan, 2008. Beneficial effects of probiotics and prebiotics in livestock and poultry: The current perspectives. Intas Polivet, 9: 1-12.
    Direct Link
  38. Dhama, K., R. Rathore, R.S. Chauhan and T. Simmi, 2005. Panchgavya: An overview. Int. J. Cow Sci., 1: 1-15.
  39. Dhama, K., V. Verma, P.M. Sawant, R. Tiwari, R.K. Vaid and R.S. Chauhan, 2011. Applications of probiotics in poultry: Enhancing immunity and beneficial effects on production performances and health: A review. J. Immunol. Immunopathol., 13: 1-19.
    Direct Link
  40. Dhur, A., P. Galan and S. Hercberg, 1991. Folate status and the immune system. Prog. Food Nutr. Sci., 15: 43-60.
    Direct Link
  41. Ferro, V.A. and E. Mordini, 2004. Peptide vaccines in immunocontraception. Curr. Opin. Mol. Ther., 6: 83-89.
    Direct Link
  42. Fischer, M.G., 2012. Sputnik and Mavirus: More than just satellite viruses. Nat. Rev. Microbiol., Vol. 10.
    CrossRefDirect Link
  43. Forton, D. and P. Karayiannis, 2006. Established and emerging therapies for the treatment of viral hepatitis. Dig. Dis., 24: 160-173.
    CrossRefDirect Link
  44. Fraile, L., E. Crisci, L. Cordoba, M.A. Navarro, J. Osada and M. Ontoya, 2012. Immunomodulatory properties of β-sitosterol in pig immune responses. Int. Immunopharmacol., 13: 316-321.
    CrossRefDirect Link
  45. Garde, D., 2012. Chemo bomb nanotechnology effective in halting tumors. http://www.fiercedrugdelivery.com/story/chemo-bomb-nanotechnology-effective-halting-tumors/2012-04-25.
  46. Goverdhana, S., M. Puntel, W. Xiong, J.M. Zirger and C. Barcia et al., 2005. Regulatable gene expression systems for gene therapy applications: Progress and future challenges. Mol. Ther., 12: 189-211.
    CrossRefDirect Link
  47. Guo, N.L., D.P. Lu, G.L. Woods, E. Reed, G.Z. Zhou, L.B. Zhang and R.H. Waldman, 1993. Demonstration of the anti-viral activity of garlic extract against human cytomegalovirus in vitro. Chinese Med. J., 106: 93-96.
    PubMedDirect Link
  48. Taddele, M.H., R. Rathore and K. Dhama, 2012. Antibiogram assay of Salmonella gallinarum and other Salmonella enterica serovars of poultry origin in India. Asian J. Anim. Vet. Adv., 7: 309-317.
    CrossRefDirect Link
  49. Hartel, C., T. Strunk, P. Bucsky and C. Schultz, 2004. Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine, 27: 101-106.
    CrossRefDirect Link
  50. Hafler, D.A., 2007. Cytokines and interventional immunology. Nat. Rev. Immunol., 7: 423-423.
    CrossRefDirect Link
  51. Hanlon, G.W., 2007. Bacteriophages: An appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents, 30: 118-128.
    CrossRefDirect Link
  52. Hansa, A., R.B. Rai, K. Dhama and M.Y. Wani, 2012. ELISA and RT-PCR based detection of bovine coronavirus in Northern India. Asian J. Anim. Vet. Adv., 7: 1120-1129.
    CrossRefDirect Link
  53. Hashemi, S.R. and H. Davoodi, 2012. Herbal plants as new immuno-stimulator in poultry industry: A review. Asian J. Anim. Vet. Adv., 7: 105-116.
    CrossRefDirect Link
  54. Hogge, G.S., J.K. Burkholder, J. Culp, M.R. Albertini, R.R. Dubielzig, N.S. Yang and E.G. MacEwen, 1999. Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs. Cancer Gene Ther., 6: 26-36.
    CrossRefDirect Link
  55. Hollmer, M., 2012. Carbon nanoparticles charge up old cancer treatment to powerful effect. FierceDrugDelivery. http://www.fiercedrugdelivery.com/story/carbon-nanoparticles-charge-old-cancer-treatment-powerful-effect/2012-02-17.
  56. Hu, L., Z. Wang, C. Hu, X. Liu, L. Yao, W. Li and Y. Qi, 2005. Inhibition of measles virus multiplication in cell culture by RNA interference. Acta Virol., 49: 227-234.
    Direct Link
  57. Jazayeri, J.A. and G.J. Carroll, 2008. Fc-based cytokines: Prospects for engineering superior therapeutics. BioDrugs, 22: 11-26.
    Direct Link
  58. Jia, F., Y.Z. Zhang and C.M. Liu, 2006. A retrovirus-based system to stably silence hepatitis B virus genes by RNA interference. Biotechnol. Lett., 28: 1679-1685.
    CrossRefDirect Link
  59. Jiang, M. and J. Milner, 2002. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene, 21: 6041-6048.
    CrossRefDirect Link
  60. Kaila, M., E. Isolauri, E. Soppi, E. Virtanen, S. Laine and H. Arvilommi, 1992. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res., 32: 141-144.
    PubMed
  61. Katona, P. and J. Katona-Apte, 2008. The interaction between nutrition and infection. Clin. Infect. Dis., 46: 1582-1588.
    CrossRefDirect Link
  62. Kovacs-Nolan, J. and Y. Mine, 2004. Avian egg antibodies: Basic and potential applications. Avian Poult. Biol. Rev., 15: 25-46.
    CrossRefDirect Link
  63. Fischer, M.G. 2011. Sputnik and Mavirus: Not more than just satellite viruses. Nat. Rev. Microbiol., 10: 78-78.
    CrossRefDirect Link
  64. Kumar, A., A.K. Verma and A. Rahal, 2011. Mycoplasma bovis, a multi disease producing pathogen: An overview. Asian J. Anim. Vet. Adv., 6: 537-546.
    CrossRefDirect Link
  65. Kumar, A., A.K. Verma, N.K. Gangwar and A. Rahal, 2012. Isolation, characterization and antibiogram of Mycoplasma bovis in sheep pneumonia. Asian J. Anim. Vet. Adv., 7: 149-157.
    CrossRefDirect Link
  66. Kumar, N., B.C. Pal, S.K. Yadav, A.K. Verma, U. Jain and G. Yadav, 2009. Prevalence of bovine brucellosis in Uttar Pradesh, India. J. Vet. Public Health, 7: 129-131.
    Direct Link
  67. Kumar, R., A.K. Verma, A. Kumar, M. Srivastava and H.P. Lal, 2012. Prevalence and antibiogram of campylobacter infections in dogs of Mathura, India. Asian J. Anim. Vet. Adv., 7: 434-440.
    CrossRefDirect Link
  68. Kumar, R., A.K. Verma, A. Kumar, M. Srivastava and H.P. Lal, 2012. Prevalence of campylobacter sp. in dogs attending veterinary practices at Mathura, India and risk indicators associated with shedding. Asian J. Anim. Vet. Adv., 7: 754-760.
    CrossRefDirect Link
  69. Kusov, Y., T. Kanda, A. Palmenberg, J.Y. Sgro and V. Gauss-Muller, 2006. Silencing of hepatitis a virus infection by small interfering RNAs. J. Virol., 80: 5599-5610.
    PubMed
  70. Sunila, E.S. and G. Kuttan, 2004. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J. Ethnopharmacol., 90: 339-346.
    CrossRefDirect Link
  71. La Scola, B., C. Desnues, I. Pagnier, C. Robert and L. Barrassi et al., 2008. The virophage as a unique parasite of the giant mimivirus. Nature, 455: 100-104.
    CrossRef
  72. Lambey, H.S., A.K. Verma, U. Jain, Mahima and B. Bist, 2009. Bacteriological quality of chevon and pork in Mathura city. J. Vet. Public Health, 7: 141-143.
    Direct Link
  73. Leklem, J.E., 2001. Vitamin B6. In: Handbook of Vitamins, Rucker, R.B., J.W. Suttie, D.B. McCormick and L.J. Machlin (Eds.). 3rd Edn. Marcel Dekker Inc., New York, pp: 339-396.
  74. Li, G., S. Andreansky, G. Helguera, M. Sepassi and N. Janikashvili et al., 2008. A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model. Mol. Cancer Ther., 7: 721-729.
    CrossRef
  75. Li, L.C., S.T. Okino, H. Zhao, D. Pookot and R.F. Place et al., 2006. Small dsRNAs induce transcriptional activation in human cells. Sci. Signall., 103: 17337-17342.
    CrossRefDirect Link
  76. Lindvall, O. and Z. Kokaia, 2006. Stem cells for the treatment of neurological disorders. Nature, 441: 1094-1096.
    CrossRef
  77. Livingston, I.L., 1993. HIV/AIDS control in Africa: The importance of epidemiological and health promotion approaches. Health Promot. Int., 8: 189-198.
    CrossRef
  78. Lu, T.K. and M.S. Koeris, 2011. The next generation of bacteriophage therapy. Curr. Opin. Microbiol., 14: 524-531.
    CrossRef
  79. Mahima, A.K. Garg and V. Mudgal, 2012. Influence of sodium selenite on growth, nutrient utilization and selenium uptake in Cavia porcellus. Pak. J. Biol. Sci., 15: 448-453.
    CrossRefDirect Link
  80. Mahima, A. Rahal, R. Deb, S.K. Latheef and H.A. Samad et al., 2012. Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines. Pak. J. Biol. Sci., 15: 754-774.
    CrossRefDirect Link
  81. Mahima, A.K. Verma, A. Kumar, A. Rahal, V. Kumar and D. Roy, 2012. Inorganic versus organic selenium supplementation: A review. Pak. J. Biol. Sci., 15: 418-425.
    CrossRefDirect Link
  82. Chaudhary, M., A.K. Garg, G.K. Mittal and V. Mudgal, 2010. Effect of organic selenium supplementation on growth, se uptake and nutrient utilization in guinea pigs. Biol. Trace Elem. Res., 133: 217-226.
    CrossRefDirect Link
  83. Malik, S., A.K. Verma, A. Kumar, M.K. Gupta and S.D. Sharma, 2012. Incidence of calf diarrhea in cattle and buffalo calves in Uttar Pradesh, India. Asian J. Anim. Vet. Adv., 7: 1049-1054.
    CrossRefDirect Link
  84. Mathur, M.D., S. Vidhani and P.L. Mehndiratta, 2003. Bacteriophage therapy: An alternative to conventional antibiotics. J. Assoc. Physicians India, 51: 593-596.
    PubMedDirect Link
  85. Mengeling, W.L., S.L. Brockmeier, K.M. Lager and A.C. Vorwald, 1997. The role of biotechnologically engineered vaccines and diagnostics in pseudorabies (Aujeszky's disease) eradication strategies. Vet. Microbiol., 55: 49-60.
    CrossRef
  86. Mercenier, A., U. Wiedermann and H. Breiteneder, 2001. Edible genetically modified microorganisms and plants for improved health. Curr. Opin. Biotechnol., 12: 510-515.
    CrossRef
  87. Meydani, S.N., S.N. Han and D. Wu, 2005. Vitamin E and immune response in the aged: Molecular mechanisms and clinical implications. Immunol. Rev., 205: 269-284.
    CrossRef
  88. Michael, A., S. Meenatchisundaram, G. Parameswari, T. Subbraj, R. Selvakumaran and S. Ramalingam, 2010. Chicken egg yolk antibodies (IgY) as an alternative to mammalian antibodies. Indian J. Sci. Technol., 3: 468-474.
    Direct Link
  89. Minchin, R., 2008. Nanomedicine: Sizing up targets with nanoparticles. Nature Nanotechnol., 3: 12-13.
    CrossRefDirect Link
  90. Mine, Y. and J. Kovacs-Nolan, 2002. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: A review. J. Med. Food, 5: 159-169.
    CrossRefDirect Link
  91. Agha-Mohammadi, S. and M.T. Lotze, 2000. Regulatable systems: Applications in gene therapy and replicating viruses. J. Clin. Invest., 105: 1177-1183.
    CrossRef
  92. Monier, A., J.M. Claverie and H. Ogata, 2008. Taxonomic distribution of large DNA viruses in the sea. Genome. Biol., Vol. 9.
    CrossRef
  93. Monosson, E., 2005. Chemical mixtures: Considering the evolution of toxicology and chemical assessment. Environ. Health Perspect., 113: 383-390.
    CrossRef
  94. Morton, J.P., P. Timpson, S.A. Karim, R.A. Ridgway and D. Athineos et al., 2010. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc. Natl. Acad. Sci. USA., 107: 246-251.
    CrossRef
  95. Natesan, S., J.M. Kataria, K. Dhama, N. Bhardwaj and A. Sylvester, 2006. Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in Rous sarcoma virus-induced tumours in chicken. J. Gen. Virol., 87: 2933-2940.
    CrossRefPubMedDirect Link
  96. Nicholls, E.F., L. Madera and R.E.W. Hancock, 2010. Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Ann. N. Y. Acad. Sci., 1213: 46-61.
    CrossRef
  97. Nielsen, K.H., M.D. Henning and J.R. Duncan, 1986. Monoclonal antibodies in veterinary medicine. Biotechnol. Genet. Eng. Rev., 4: 311-353.
  98. Ohnishi, K., Z. Scuric, R.H. Schiestl, N. Okamoto, A. Takahashi and T. Ohnishi, 2006. siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status. Radiat. Res., 166: 454-462.
    PubMedDirect Link
  99. Oka, Y. and H. Sugiyama, 2010. WT1 peptide vaccine, one of the most promising cancer vaccines: Its present status and the future prospects. Immunotherapy, 2: 591-594.
    CrossRefDirect Link
  100. Openheimer, S.J., 2001. Iron and its relation to immunity and infectious disease. J. Nutr., 131: 616S-633S.
    PubMedDirect Link
  101. Paddison, P.J., A.A. Caudy and G.J. Hannon, 2002. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. USA., 99: 1443-1448.
    CrossRefPubMedDirect Link
  102. Park, J.H., J.I. Um, B.J. Lee, J.S. Goh, S.Y. Park, W.S. Kim and P.H. Kim, 2002. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol., 219: 22-27.
    CrossRef
  103. Pathania, S., P. Kumar, L.G. Devi, D. Kumar, K. Dhama and R. Somvanshi, 2011. Preliminary assessment of binary ethylenimine inactivated and saponized cutaneous warts (BPV-2) therapeutic vaccine for enzootic bovine haematuria in hill cows. Vaccine, 29: 7296-7302.
    PubMedDirect Link
  104. Patyal, A., R.S. Rathore, H.V. Mohan, K. Dhama and A. Kumar, 2011. Prevalence of Arcobacter spp. in humans, animals and foods of animal origin including sea food from India. Transboundary Emerg. Dis., 58: 402-410.
    CrossRefDirect Link
  105. Pawaiya, R.V.S., K. Dhama, M. Mahendran and B.N. Tripathi, 2009. Swine flu and the current influenza A (H1N1) pandemic in humans: A review. Indian J. Vet. Pathol., 33: 1-17.
    Direct Link
  106. Pejawar-Gaddy, S. and O.J. Finn, 2008. Cancer vaccines: Accomplishments and challenges. Crit. Rev. Oncol. Hematol., 67: 93-102.
    CrossRef
  107. Pizarro, T.T. and F. Cominelli, 2007. Cytokine therapy for Crohn's disease: Advances in translational research. Annu. Rev. Med., 58: 433-444.
    CrossRefPubMedDirect Link
  108. Raghunath, D., 2008. Emerging antibiotic resistance in bacteria with special reference to India. J. Biosci., 33: 593-603.
    Direct Link
  109. Rahman, S.A., 2010. Doctors scoff at hindu health drink containing cow urine. The National, (Abu Dhabi).
  110. Ramakrishnan, U., A.L. Web and K. Ologoudou, 2004. Infection, Immunity and Vitamins. In: Handbook of Nutrition and Immunity, Gershwin, N.E., P. Nestel and C.L. Keen (Eds.). Humana Press, Totoja, NJ., pp: 93-115.
  111. Raoul, C., S. Barker and P. Aebischer, 2006. Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene. Ther., 13: 487-495.
    CrossRefPubMedDirect Link
  112. Rhoads, D.D., R.D. Wolcott, M.A. Kuskowski, B.M. Wolcott, L.S. Ward and A. Sulakvelidze, 2009. Bacteriophage therapy of venous leg ulcers in humans: Results of a phase I safety trial. J. Wound Care, 18: 237-238, 240-243.
    PubMedDirect Link
  113. Sah, D.W.Y., 2006. Therapeutic potential of RNA interference for neurological disorders. Life Sci., 79: 1773-1780.
    CrossRefPubMedDirect Link
  114. Sharma, H., S. Sen, L. Lo Muzio, N. Mraiggio and N. Singh, 2005. Antisense-mediated downregulation of antiapoptotic proteins induces apoptosis and sensitises head and neck squamous cell carcinoma cells to chemotherapy. Cancer Biol. Ther., 4: 720-727.
    PubMedDirect Link
  115. Shirley, M.W., B. Charleston and D.P. King, 2011. New opportunities to control livestock diseases in the post-genomics era. J. Agric. Sci., 149: 115-121.
    CrossRefDirect Link
  116. Singh, C.P., A.K. Verma and B.C. Pal, 2008. Prevalence of protected animals against foot and mouth disease in Uttar Pradesh. Haryana Vet., 47: 107-109.
    Direct Link
  117. Singh, R., P.P. Singh, R.S. Rathore, K. Dhama and S.V.S. Malik, 2009. Prevalence of Campylobacter jejuni and Campylobacter coli in chicken meat and carcasses collected from local poultry farms and retail shops of Bareilly, Uttar Pradesh India. Indian J. Comp. Microbiol. Immunol. Infect. Dis., 30: 35-38.
    Direct Link
  118. Singh, V.K., S. Biswas, K.B. Mathur, W. Haq, S.K. Garg and S.S. Agarwal, 1998. Thymopentin and splenopentin as immunomodulators. Immunol. Res., 17: 345-368.
    CrossRefPubMedDirect Link
  119. Sulakvelidz, A., 2011. The challenges of bacteriophage therapy. Eur. Ind. Pharmacy, 10: 14-18.
    Direct Link
  120. Sulakvelidze, A., Z. Alavidze and J.G. Morris Jr., 2001. Bacteriophage therapy. Antimicrob. Agents Chemother., 45: 649-659.
    CrossRefDirect Link
  121. Suzuki, K. and H. Matsubara, 2011. Recent advances in p53 research and cancer treatment. J. Biomed. Biotech., Vol. 2011.
    CrossRefDirect Link
  122. Tamura, J., K. Kubota, H. Murakami, M. Sawamura and T. Matsushima et al., 1999. Immunomodulation by vitamin B12: Augmentation of CD8pT lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin. Exp. Immunol., 116: 28-32.
    CrossRefDirect Link
  123. Tiwari, R., K. Dhama, M.Y. Wani, V. Verma, R.K. Vaid and R.S. Chauhan, 2011. Bacteriophage therapy: A novel tool for combating bacterial diseases of poultry-A review. J. Immunol. Immunopathol., 13: 55-66.
    Direct Link
  124. Tiwari, R., S.D. Hirpurkar and K. Dhama, 2012. Therapeutic Potential of Bacteriophages against Pathogenic Bacteria. LAP LAMBERT Academic Publishing, Germany, pp: 1-108.
  125. Trapero-Marugan, M., L. Garcia-Buey, C. Munoz, N.E. Quintana and J.A. Moreno-Monteagudo et al., 2006. Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response. Aliment. Pharmacol. Ther., 24: 117-128.
    CrossRefPubMedDirect Link
  126. Veldman, C.M., M.T. Cantorna and H.F. DeLuca, 2000. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch. Biochem. Biophys., 374: 334-338.
    CrossRefPubMedDirect Link
  127. Verma, A.K., 2005. Cowpathy and human health. Indian Cow: Scient. Econ. J., 2: 39-45.
  128. Verma, A.K., A. Kumar, M. Mahima and S. Sahzad, 2012. Epidemiology and diagnosis of foot-and-mouth disease: A review. Indian J. Anim. Sci., 82: 543-551.
    Direct Link
  129. Verma, A.K., B.C. Pal, C.P. Singh, U. Jain, S.K. Yadav and Mahima, 2008. Studies of the outbreaks of foot and mouth disease in Uttar Pradesh, India, between 2000 and 2006. Asian J. Epidemiol., 1: 40-46.
    CrossRefDirect Link
  130. Verma, A.K., D.K. Sinha and B.R. Singh, 2007. Salmonellosis in apparently healthy dogs. J. Vet. Public Health, 5: 37-39.
    Direct Link
  131. Verma, A.K., D.K. Sinha and B.R. Singh, 2008. Micro-Agglutination Test (MAT) based sero-epidemiological study of salmonellosis in dogs. J. Immunol. Immunopathol., 10: 29-35.
    Direct Link
  132. Verma, A.K., D.K. Sinha and B.R. Singh, 2011. Seroprevalence study on salmonellosis in apparently healthy dogs by enzyme linked immunosobent assay. Indian J. Anim. Sci., 81: 3-5.
  133. Verma, A.K., D.K. Sinha and B.R. Singh, 2011. Detection of Salmonella from clinical samples of dogs by PCR. Indian J. Anim. Sci., 81: 552-555.
    Direct Link
  134. Wilckens, T. and R. de Rijk, 1997. Glucocorticoids and immune function: Unknown dimensions and new frontiers. Immunol. Today, 18: 418-424.
    PubMedDirect Link
  135. Wong, R.S.Y., 2011. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res., Vol. 30.
    CrossRefDirect Link
  136. Woods, N.B., V. Bottero, M. Schmidt, C. Von Kalle and I.M. Verma, 2006. Gene therapy: Therapeutic gene causing lymphoma. Nature, 440: 1123-1123.
    CrossRefDirect Link
  137. Ardhanareeswaran, K. and M. Mirotsou, 2013. Lung stem and progenitor cells. Respiration, 85: 89-95.
    CrossRefPubMedDirect Link
  138. Cardenes, N., E. Caceres, M. Romagnoli and M. Rojas, 2013. Mesenchymal stem cells: A promising therapy for the acute respiratory distress syndrome. Respiration, 15: 267-278.
    CrossRefPubMedDirect Link
  139. Desnues, C., M. Boyer and D. Raoult, 2012. Sputnik, a virophage infecting the viral domain of life. Adv. Virus Res., 82: 63-89.
    CrossRefPubMedDirect Link
  140. Dhama, K., M.S. Basaraddi, R. Tiwari and L.R. Ananthakrshna, 2011. Egg Yolk Antibodies (EYA). Poul. Technol., 6: 20-24.
  141. Fryer, B.H., A. Rezania and M.C. Zimmerman, 2013. Generating β-cells in vitro: Progress towards a holy grail. Curr. Opin. Endocrinol. Diabetes Obes., 20: 112-117.
    PubMedDirect Link
  142. Irache, J.M., I. Esparza, C. Gamazo, M. Agueros and S. Espuelas, 2011. Nanomedicine: Novel approaches in human and veterinary therapeutics. Vet. Parasitol., 180: 47-71.
    CrossRefPubMedDirect Link
  143. Jiang, W., J. Peng, Y. Zhang, W.C.S. Cho and K. Jin, 2012. The implications of cancer stem cells for cancer therapy. Int. J. Mol. Sci., 13: 16636-16657.
    CrossRefPubMedDirect Link
  144. Kato, K., 2013. Development trend of nanomedicines. Yakugaku Zasshi, 133: 43-51 [Article in Japanese].
    PubMedDirect Link
  145. Kieler-Ferguson, H.M., J.M.J. Frechet and F.C. Szoka Jr., 2013. Clinical developments of chemotherapeutic nanomedicines: Polymers and liposomes for delivery of camptothecins and platinum (II) drugs. WIREs Nanomed. Nanobiotechnol., 5: 130-138.
    CrossRefPubMedDirect Link
  146. Krupovic, M. and V. Cvirkaite-Krupovic, 2011. Virophages or satellite viruses? Nat. Rev. Microbiol., 9: 762-763.
    CrossRefPubMedDirect Link
  147. Menzel-Severing, J., F.E. Kruse and U. Schlotzer-Schrehardt, 2013. Stem cell-based therapy for corneal epithelial reconstruction: Present and future. Can. J. Ophthalmol., 48: 13-21.
    PubMed
  148. Ouyang, X.Y. and W. Yang, 2013. Translational medicine and its application in stem cell research for periodontal regeneration. Beijing Da Xue Xue Bao., 45: 152-155 [Article in Chinese].
    PubMedDirect Link
  149. Ribitsch, I., J. Burk, U. Delling, C. Geiβler, C. Gittel, H. Julke and W. Brehm, 2010. Basic science and clinical application of stem cells in veterinary medicine. Adv. Biochem. Eng. Biotechnol., 123: 219-263.
    CrossRefPubMedDirect Link
  150. Rahimi, S., E. Salehifar, S.A. Ghorashi, J.L. Grimes and M.A.K. Torshizi, 2007. The effect of egg-derived antibody on prevention of avian influenza subtype H9N2 in layer chicken. Int. J. Poult. Sci., 6: 207-210.
    CrossRefDirect Link
  151. Siccardi, M., P. Martin, T.O. McDonald, N.J. Liptrott, M. Giardiello, S. Rannard and A. Owen, 2013. Nanomedicines for HIV therapy. Ther. Deliv., 4: 153-156.
    CrossRefPubMedDirect Link
  152. Singh, D., A.K. Verma, A. Kumar, M.K. Srivastava and S.K. Singh et al., 2013. Detection of canine parvo virus by polymerase chain reaction assay and its prevalence in dogs in and around Mathura, Uttar Pradesh, India. Am. J. Biochem. Mol. Biol.
  153. Underwood, C. and A.W. van Eps, 2012. Nanomedicine and veterinary science: The reality and the practicality. Vet. J., 193: 12-23.
    CrossRefPubMedDirect Link
  154. Da Silva, W.D. and D.V. Tambourgi, 2010. IgY: A promising antibody for use in immunodiagnostic and in immunotherapy. Vet. Immunol. Immunopathol., 135: 173-180.
    CrossRefDirect Link
  155. Coppel, R. and S.S. Kulkarni, 2012. Synthetic carbohydrate antigens as potent immunomodulators. Project No. IMURA0272, IITB-Monash Research Academy, MONASH University, Indian Institute of Technology, Bombay. http://www.iitbonash.org.
  156. Rai, K.R., J. Moore, J. Wu, S.C. Novick and S.M. O'Brien, 2008. Effect of the addition of oblimersen (Bcl-2 antisense) to fludarabine/cyclophosphamide for replased/refractory Chronic Lymphocytic Leukaemia (CLL) on survival in patients who achieve CR/nPR: Five-year follow-up from a randomized phase III study. J. Clin. Oncol., Vol. 26.
  157. Trafton, A., 2012. Target: Drug-resistant bacteria. MIT news. http://web.mit.edu/newsoffice/2012/antibiotic-nanoparticle-0504.html.
  158. Yegani, M. and D.R. Korver, 2007. Application of egg yolk antibodies as replacement for antibiotics in poultry. World Poul., 23: 22-25.
  159. Wen, Z., Q. Liao, Y. Hu, S. Liu, L. You and Y. Zhao, 2013. Human adipose-derived stromal/stem cells: A novel approach to inhibiting acute pancreatitis. Med. Hypotheses.
    CrossRef

Search

Leave a Comment

Your email address will not be published. Required fields are marked *